AZD4956
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AZD4956, covering 2026-04-20 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: Study of AZD4956 as Monotherapy and in Combination With Anti-Cancer Agents in Participants With Advanced/Metastatic Homologous Recombination Deficient Solid Tumours [Phase 1, Phase 2]